HAVCR2 and neoplasm: Since there is a possibility of blocking Tim-3 signaling to enhance antivirus and antitumor immunity, researchers have combined anti–Tim-3 and anti–PD-L1 treatment in patients which resulted in a dramatic reduction in tumor growth while restored strong antivirus immunity [4], [25], [26], [27].